Physician

Rajinder Singh, M.D.

According to 2025 Medicare claims, Rajinder Singh, M.D. (NPI: 1518007889) practices cardiology in the Santa Cruz-Watsonville, CA market, with the plurality of this provider's patient population coming from Santa Cruz, CA. This provider's primary affiliated billing organization is CARDIOVASCULAR ASSOCIATES OF SANTA CRUZ (NPI: 1063858058; TIN: 462675362) and primary practice location at 95065-1560.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,550 traditional Medicare patients, billed 7,780 HCPCS/CPT codes, and received $614,942 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 8,482 prescription claims across 1,152 beneficiaries totaling $1,732,858 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 12 claims. Open Payments data shows 8 records totaling $455. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $509,648 to $1,732,858. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,632	14,004	$666,024
2016	1,515	14,202	$645,563
2017	1,654	12,798	$618,658
2018	1,610	13,386	$620,915
2019	1,721	12,969	$672,092
2020	1,474	10,832	$529,927
2021	1,611	12,895	$722,511
2022	1,664	11,478	$706,564
2023	1,662	12,487	$715,199
2024	1,550	7,780	$614,942

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	858	7,549	$509,648
2016	887	7,826	$647,399
2017	923	7,750	$708,314
2018	964	7,743	$845,822
2019	997	7,953	$1,001,678
2020	970	7,556	$1,043,626
2021	1,045	7,842	$1,303,360
2022	1,130	8,299	$1,917,778
2023	1,189	8,445	$1,801,906
2024	1,152	8,482	$1,732,858

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$570
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	203	206	$361
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	585	637	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	941	1,732	$91
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	198	402	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	473	578	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	594	41,010	$787,662
Entresto	Sacubitril/Valsartan	189	11,188	$245,053
Xarelto	Rivaroxaban	110	7,835	$145,626
Multaq	Dronedarone Hcl	60	4,480	$114,576
Repatha Sureclick	Evolocumab	78	3,472	$67,464

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$455	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajinder Singh, M.D.?

Tedicare shows public-source Medicare data for Rajinder Singh, M.D. (NPI 1518007889), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajinder Singh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rajinder Singh, M.D.?

Rajinder Singh, M.D. is linked to CARDIOVASCULAR ASSOCIATES OF SANTA CRUZ (billing NPI 1063858058) in the available physician profile data.

Does Rajinder Singh, M.D. have Open Payments data?

Rajinder Singh, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.